- KT and NeuroSigma partner to jointly develop and commercialize neuroelectronic ADHD therapies inside and outside of Korea - Partnership...

CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company focused on developing first-in-class...

BOSTON--(BUSINESS WIRE)--Elucid, a medical technology company developing AI software to enable cardiovascular disease detection, today...